CONTINUE TO SITE ➞

Don't miss tomorrow's biopharma industry news

Let BioPharma Dive's free newsletter keep you informed, straight from your inbox.

Daily Dive M-F

Commercialization Weekly Every Wednesday

Gene Therapy Weekly Every Thursday

Emerging Biotech Weekly Every Tuesday

By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Deep Dive
Library
Events
Press Releases

Pharma
Biotech
FDA
Clinical Trials
Deals
Drug Pricing
Gene Therapy

What We're Reading: Page 336

Industry reads hand-picked by our editors

Jun 24, 2016

The Street
Sarepta Push for Duchenne Drug Approval Helped by Clinical Trial Changes
Stat
Bill introduced to speed cheaper versions of pricey biologics to market
EP Vantage
Valuable late-stage pipeline sets 2017 up for some big events
PharmaTimes
EU nod for Gilead’s single-pill HIV therapy

Jun 23, 2016

The Hill
New shots fired in drug pricing war
Bloomberg
Mylan Says Indian Drug Industry Needs More Transparency From FDA
Reuters
Republican lawmakers approve $1.1 billion in new Zika funds
Forbes
NEA Leads $44M Bet That Protecting Synapses Will Help Fight Alzheimer's

Jun 22, 2016

Reuters
India to revise drugs law, draft new rules for medical devices
Stat
At 31, she runs one of the hottest biotech companies in the country
FierceBiotech
Axon’s Alzheimer’s vaccine hits Phase II as it seeks to prove efficacy
PMLive
NICE backs five new drugs after discounts agreed

Jun 21, 2016

MIT Technology Review
Money Behind First CRISPR Test? It’s from Internet Billionaire Sean Parker
Bloomberg
Biotech Stocks Tumble in Longest Selloff in Two Decades: Chart
FierceBiotech
Regulus nabs $30M in debt to keep plugging at microRNA-targeting hep C candidate

Jun 20, 2016

Wall Street Journal
Circassia Shares Plunge After Trial of Experimental Cat Allergy Drug Fails
BloombergGadfly
Merck's Edge on Bristol-Myers Won't Last
Forbes
Something May Be Working At Theranos, But You Don't Know What It Is
Reuters
Inovio Pharma gets green signal to test Zika vaccine in human trial

Jun 17, 2016

Regulatory Focus
Two Indian Contract Pharma, API Manufacturers Refuse FDA Inspections
Wall Street Journal
Brexit Would Put EU Drug Regulator’s Headquarters in Play
Reuters
Scancell slumps as drug problem disrupts melanoma trial
PMLive
NICE backs first Duchenne muscular dystrophy drug

Jun 16, 2016

Reuters
Roche skin cancer drugs 'too expensive', says UK cost agency
Stat
Republicans seize on reports critiquing FDA to push for agency reforms
FierceBiotech
UniQure slides toward historic lows after its hemB gene therapy goes up against Spark

Previous Next

Get the free newsletter

Subscribe to BioPharma Dive for top news, trends & analysis

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.

Library resources

Trendline
Inside the world of cell therapies Supported by ProBio CDMO
Trendline
Inside the market strategies of today’s drugmakers Supported by Evaluate
Trendline
The latest developments on the gene therapy frontier Supported by Mirus Bio LLC

View all

Company Announcements

View all | Post a press release

Events

View all | Promote an event

Industry Intel

Revolutionizing Next Generation Gene Therapies with On-Demand Large DNA Construct Synthesis and Novel, Designable Delivery Vehicles Webinar - on demand • Provided by Ansa Biotechnologies
2026 Life Sciences AI & Data Predictions Webinar - on demand • Provided by Snowflake
Developing an Array of Diverse Vaccine Platforms Webinar - on demand • Provided by BioPharma Dive's studioID; Sponsored content by Novavax in partnership with studioID

Explore

About
Editorial Team
Contact Us
Newsletter
Purchase Licensing Rights
Press Releases
What We're Reading

Reach our audience

Advertising
Post a press release
Promote an event

Related Publications

Healthcare Dive
MedTech Dive

Industry Dive is an Informa TechTarget business.

This website is owned and operated by Informa TechTarget, part of a global network that informs, influences and connects the world's technology buyers and sellers. All copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget, Inc.'s registered office is 275 Grove St. Newton, MA 02466.

Home
- Pharma
- Biotech
- FDA
- Clinical Trials
- Deals
- Drug Pricing
- Gene Therapy
Deep Dive
Library
Events
Press Releases

Get BioPharma Dive in your inbox

The free newsletter covering the top industry headlines

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.